Business
Press Release Jun 07 2021
Lupin Limited has informed the Exchange regarding a press release dated Jun 07, 2021, titled "Lupin Receives U.S. FDA Approval for Emtricitabine and Tenofovir DisoproxilFumarate Tablets.".
About this update from Lupin Limited
[{"type":"text","content":" Lupin Limited has informed the Exchange regarding a press release dated Jun 07, 2021, titled \"Lupin Receives U.S. FDA Approval for Emtricitabine and Tenofovir DisoproxilFumarate Tablets.\". View Attachment","length":369,"tagName":"div"}]